ScripDuring its first quarter sales and earnings call on 25 April, AbbVie CEO Robert Michael expressed confidence that the company can weather the current tariffs introduced by the Trump Administration as
ScripWith biopharma investors eager for hard numbers on the impact of the Trump administration’s tariff policy on corporate financials, Merck & Co. CEO Robert Davis offered some answers on 24 April, sa
Pink SheetThe heads of two of Europe’s largest pharma companies urged the EU to increase drug prices to be more in line with the US, a move unlikely to be greeted enthusiastically in the cash-strapped continent
ScripResults from a Phase III study in China of Akeso and Summit Therapeutics’ ivonescimab in non-small cell lung cancer (NSCLC) are an encouraging sign for the PD-1/VEGF-targeting bispecific antibody’s pi